Stay updated on Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section with Florida as a site. Removed the old Florida Locations heading and the HHS Vulnerability Disclosure footer; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:20:58.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added; Revision: v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:44:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. Trial details, eligibility criteria, and study results remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Screenshots show no substantive changes to the Study Details page for NCT03245736; only minor formatting and layout variations are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:06:19.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:31:09.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Terminology updated to 'Squamous cell carcinoma of the head and neck' and page revision advanced from v3.0.2 to v3.1.0.
    Difference
    0.9%
    Check dated 2025-09-29T03:03:23.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.